Bradley C. Lega
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bradley C. Lega has a total of 272 co-authors. Here are the top co-authors by number of shared publications:
- Michael R. Sperling
Farber Institute for Neuroscience, Department of Neurology, Thomas Jefferson University, Philadelphia, USA
14 shared publications - Michael J. Kahana
University of Pennsylvania
12 shared publications Gray Umbach
Department of Neurological Surgery, University of California San Francisco, San Francisco, USA
9 shared publications- Joshua Jacobs
Department of Biomedical Engineering, Columbia University
9 shared publications - Barbara C. Jobst
Geisel School of Medicine at Dartmouth, USA
8 shared publications - Robert E. Gross
Department of Neurosurgery Emory University Atlanta Georgia USA
8 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Cholinergic blockade reveals a role for human hippocampal theta in memory encoding but not retrieval
Cholinergic dysfunction is a hallmark of Alzheimer’s disease and other memory disorders. Yet, the neurophysiological mechanisms linking cholinergic signaling to memory remain poorly understood. In this study, we administered scopolamine, a muscarinic cholinergic antagonist, to neurosurgical patients with intracranial electrodes as they performed an associative recognition memory task. When scopolamine was present at encoding, we observed disruptions to hippocampal slow theta oscillations (2–4 Hz), with selective impairments to recollection-based memory. However, when scopolamine was present during retrieval alone, we observed disruptions to slow theta without impaired memory performance. These disruptions included dose-dependent reductions in theta power, theta phase reset, and encoding–retrieval pattern reinstatement. Together, our results challenge the notion that theta oscillations are necessary for memory retrieval, and instead suggest that theta universally reflects an encoding-related neural state. These findings motivate updates to current models of acetylcholine’s role in memory and may inform future therapies targeting rhythmic biomarkers of memory dysfunction.
- 11 November 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Open AccessCholinergic blockade reveals a role for human hippocampal theta in memory encoding but not retrieval
Cholinergic dysfunction is a hallmark of Alzheimer’s disease and other memory disorders. Yet, the neurophysiological mechanisms linking cholinergic signaling to memory remain poorly understood. In this study, we administered scopolamine, a muscarinic cholinergic antagonist, to neurosurgical patients with intracranial electrodes as they performed an associative recognition memory task. When scopolamine was present at encoding, we observed disruptions to hippocampal slow theta oscillations (2–4 Hz), with selective impairments to recollection-based memory. However, when scopolamine was present during retrieval alone, we observed disruptions to slow theta without impaired memory performance. These disruptions included dose-dependent reductions in theta power, theta phase reset, and encoding–retrieval pattern reinstatement. Together, our results challenge the notion that theta oscillations are necessary for memory retrieval, and instead suggest that theta universally reflects an encoding-related neural state. These findings motivate updates to current models of acetylcholine’s role in memory and may inform future therapies targeting rhythmic biomarkers of memory dysfunction.
- 5 August 2026
- Published by Springer Nature in Nature
- Vol. 657 (8132) , 724-734
Stimulation modulates gene-linked cell assemblies in the human brain
- 5 August 2026
- Published by Springer Nature in Nature
- Vol. 657 (8132) , 724-734
Stimulation modulates gene-linked cell assemblies in the human brain
- Open Access
Personalized Intracranial Circuit-Guided Deep Brain Stimulation for Treatment-Resistant Schizophrenia
We report a pilot study of deep brain stimulation (DBS) in three individuals with treatment refractory schizophrenia (TRS). DBS target selection was supported by an inpatient brain network mapping paradigm using intracranial electroencephalography. In conjunction with assessing stimulation-dependent symptom improvement, we derived spatiotemporally resolved profiles of psychosis and healthy brain states and identified stimulation targets that best shifted brain networks towards healthy states. Therapeutic stimulation sites were personalized for each participant but converged on salience network nodes including anterior cingulate and anterior insula. No significant adverse events were noted across participants. Moreover, two participants with chronic stimulation and clinical follow-up of at least 4 months reported significant improvement in both positive and negative symptoms, and treatment optimization is underway for the third. These critical pilot data establish the feasibility of personalized DBS guided by concurrent stimulation mapping, behavioral assessment, and biomarker monitoring as a treatment for TRS.
Open AccessPersonalized Intracranial Circuit-Guided Deep Brain Stimulation for Treatment-Resistant Schizophrenia
We report a pilot study of deep brain stimulation (DBS) in three individuals with treatment refractory schizophrenia (TRS). DBS target selection was supported by an inpatient brain network mapping paradigm using intracranial electroencephalography. In conjunction with assessing stimulation-dependent symptom improvement, we derived spatiotemporally resolved profiles of psychosis and healthy brain states and identified stimulation targets that best shifted brain networks towards healthy states. Therapeutic stimulation sites were personalized for each participant but converged on salience network nodes including anterior cingulate and anterior insula. No significant adverse events were noted across participants. Moreover, two participants with chronic stimulation and clinical follow-up of at least 4 months reported significant improvement in both positive and negative symptoms, and treatment optimization is underway for the third. These critical pilot data establish the feasibility of personalized DBS guided by concurrent stimulation mapping, behavioral assessment, and biomarker monitoring as a treatment for TRS.
- Open Access
- 14 July 2026
- Published by Elsevier in Neuropsychologia
- Vol. 231, 109542
Decoding order memory representations using high-frequency activity in the human neocortex
- 14 July 2026
- Published by Elsevier in Neuropsychologia
- Vol. 231, 109542
Open AccessDecoding order memory representations using high-frequency activity in the human neocortex
- Open Access
The genetic signature of memory encoding along the human hippocampal axis
Episodic memory formation engages hippocampal oscillations that vary along the anterior-posterior axis, but the molecular programs supporting this physiological specialization remain unclear. Here, we leveraged a rare neurosurgical dataset in which patients performed verbal episodic memory tasks during intrahippocampal intracranial EEG recordings prior to en bloc hippocampal resection, enabling integration of encoding-related oscillatory signatures with matched cell-type-resolved transcriptomics from the same individuals. Subsequent memory effects (SMEs) spanned delta/theta, gamma, and hippocampal ripple activity across anterior and posterior hippocampus. Single-nucleus RNA sequencing from anatomically matched anterior and posterior tissue revealed longitudinal transcriptional gradients, most prominent in excitatory neurons. Spatial transcriptomic maps validated axis-enriched transcripts and their localization. Linking subject-specific SMEs to gene expression identified distinct molecular programs: anterior low frequency SMEs associated with synaptic and chromatin-regulatory pathways, and posterior high-frequency SMEs associated with metabolic and protein synthesis processes. Gene regulatory network inference further revealed axis-specific hub architectures. Together, these results define a cell-type-specific genetic architecture linking longitudinal molecular specialization to the human hippocampal encoding dynamics.
Open AccessThe genetic signature of memory encoding along the human hippocampal axis
Episodic memory formation engages hippocampal oscillations that vary along the anterior-posterior axis, but the molecular programs supporting this physiological specialization remain unclear. Here, we leveraged a rare neurosurgical dataset in which patients performed verbal episodic memory tasks during intrahippocampal intracranial EEG recordings prior to en bloc hippocampal resection, enabling integration of encoding-related oscillatory signatures with matched cell-type-resolved transcriptomics from the same individuals. Subsequent memory effects (SMEs) spanned delta/theta, gamma, and hippocampal ripple activity across anterior and posterior hippocampus. Single-nucleus RNA sequencing from anatomically matched anterior and posterior tissue revealed longitudinal transcriptional gradients, most prominent in excitatory neurons. Spatial transcriptomic maps validated axis-enriched transcripts and their localization. Linking subject-specific SMEs to gene expression identified distinct molecular programs: anterior low frequency SMEs associated with synaptic and chromatin-regulatory pathways, and posterior high-frequency SMEs associated with metabolic and protein synthesis processes. Gene regulatory network inference further revealed axis-specific hub architectures. Together, these results define a cell-type-specific genetic architecture linking longitudinal molecular specialization to the human hippocampal encoding dynamics.
- Open Access
- 27 February 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 14
Cholinergic blockade reveals a role for human hippocampal theta in memory encoding but not retrieval
Cholinergic dysfunction is a hallmark of Alzheimer’s disease and other memory disorders. Yet, the neurophysiological mechanisms linking cholinergic signaling to memory remain poorly understood. In this study, we administered scopolamine, a muscarinic cholinergic antagonist, to neurosurgical patients with intracranial electrodes as they performed an associative recognition memory task. When scopolamine was present at encoding, we observed disruptions to hippocampal slow theta oscillations (2–4 Hz), with selective impairments to recollection-based memory. However, when scopolamine was present during retrieval alone, we observed disruptions to slow theta without impaired memory performance. These disruptions included dose-dependent reductions in theta power, theta phase reset, and encoding–retrieval pattern reinstatement. Together, our results challenge the notion that theta oscillations are necessary for memory retrieval, and instead suggest that theta universally reflects an encoding-related neural state. These findings motivate updates to current models of acetylcholine’s role in memory and may inform future therapies targeting rhythmic biomarkers of memory dysfunction.
- 27 February 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 14
Open AccessCholinergic blockade reveals a role for human hippocampal theta in memory encoding but not retrieval
Cholinergic dysfunction is a hallmark of Alzheimer’s disease and other memory disorders. Yet, the neurophysiological mechanisms linking cholinergic signaling to memory remain poorly understood. In this study, we administered scopolamine, a muscarinic cholinergic antagonist, to neurosurgical patients with intracranial electrodes as they performed an associative recognition memory task. When scopolamine was present at encoding, we observed disruptions to hippocampal slow theta oscillations (2–4 Hz), with selective impairments to recollection-based memory. However, when scopolamine was present during retrieval alone, we observed disruptions to slow theta without impaired memory performance. These disruptions included dose-dependent reductions in theta power, theta phase reset, and encoding–retrieval pattern reinstatement. Together, our results challenge the notion that theta oscillations are necessary for memory retrieval, and instead suggest that theta universally reflects an encoding-related neural state. These findings motivate updates to current models of acetylcholine’s role in memory and may inform future therapies targeting rhythmic biomarkers of memory dysfunction.
- Open Access
- 19 January 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (3)
Laser interstitial thermal therapy with a previously implanted responsive neurostimulation device: a multicenter experience. Illustrative cases
BACKGROUND: Responsive neurostimulation (RNS) enables real-time electrographic monitoring and chronic assessment of seizure burden in two distinct brain regions. Laser interstitial thermal therapy (LITT) offers a minimally invasive treatment for mesial temporal epilepsy. Unilateral LITT that maintains functional RNS contralaterally poses significant challenges. As RNS use becomes more widespread, adjunctive seizure reduction therapies following implantation may become increasingly common. The authors present 2 cases illustrating a minimally invasive surgical approach. OBSERVATIONS: Two patients with bitemporal RNS underwent long-term monitoring that revealed a significant unilateral predominance in seizure onset. LITT targeting the more active mesial temporal lobe while maintaining a functioning RNS contralaterally was recommended. Mesial temporal laser ablations were performed that accounted for existing RNS hardware and manufacturer-imposed MRI safety limitations. Both patients retained fully functional RNS systems postoperatively and experienced no complications. The laser ablations were technically successful with encouraging early seizure freedom outcomes. Long-term monitoring will determine sustained efficacy. LESSONS: LITT was safely performed in the prone position in 2 patients with preexisting RNS systems. Caution is required to avoid hardware damage or electrode overheating during MRI. While further study is needed to assess outcomes, this technique offers a promising option for patients requiring targeted ablation following extended RNS monitoring. https://thejns.org/doi/10.3171/CASE25434
- 19 January 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (3)
Open AccessLaser interstitial thermal therapy with a previously implanted responsive neurostimulation device: a multicenter experience. Illustrative cases
BACKGROUND: Responsive neurostimulation (RNS) enables real-time electrographic monitoring and chronic assessment of seizure burden in two distinct brain regions. Laser interstitial thermal therapy (LITT) offers a minimally invasive treatment for mesial temporal epilepsy. Unilateral LITT that maintains functional RNS contralaterally poses significant challenges. As RNS use becomes more widespread, adjunctive seizure reduction therapies following implantation may become increasingly common. The authors present 2 cases illustrating a minimally invasive surgical approach. OBSERVATIONS: Two patients with bitemporal RNS underwent long-term monitoring that revealed a significant unilateral predominance in seizure onset. LITT targeting the more active mesial temporal lobe while maintaining a functioning RNS contralaterally was recommended. Mesial temporal laser ablations were performed that accounted for existing RNS hardware and manufacturer-imposed MRI safety limitations. Both patients retained fully functional RNS systems postoperatively and experienced no complications. The laser ablations were technically successful with encouraging early seizure freedom outcomes. Long-term monitoring will determine sustained efficacy. LESSONS: LITT was safely performed in the prone position in 2 patients with preexisting RNS systems. Caution is required to avoid hardware damage or electrode overheating during MRI. While further study is needed to assess outcomes, this technique offers a promising option for patients requiring targeted ablation following extended RNS monitoring. https://thejns.org/doi/10.3171/CASE25434
- Open Access
- 20 December 2025
- Published by Elsevier in Brain Stimulation
- Vol. 19 (1) , 103013
A wireless, 60-channel, AI-enabled neurostimulation platform
- 20 December 2025
- Published by Elsevier in Brain Stimulation
- Vol. 19 (1) , 103013
Open AccessA wireless, 60-channel, AI-enabled neurostimulation platform
- Open Access
- 25 October 2025
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (2) , 415-429
Stable isotope tracing in human plasma-like medium reveals metabolic and immune modulation of the glioblastoma microenvironment
Background: In vivo stable isotope tracing is useful for natively surveying glioma metabolism but can be difficult to implement. Stable isotope tracing is tractable using in vitro glioma models, but most models lack nutrient conditions and cell populations relevant to human gliomas. This limits our ability to study glioma metabolism in the presence of an intact tumor microenvironment (TME) and immune-metabolic crosstalk. Methods: We optimized an in vitro stable isotope tracing approach for human glioma explants and glioma stem-like cell (GSC) lines that integrates human plasma-like medium (HPLM). We performed 15N2-glutamine tracing in GSC monocultures and human IDH-wildtype glioblastoma explants and developed an analytical framework to evaluate microenvironment-dependent metabolic features that distinguish them. We also conducted spatial transcriptomics to assess transcriptional correlates to metabolic activities. Results: Human plasma-like medium culture preserved glioma explant viability and stemness while unmasking metabolic and immune programs suppressed by conventional culture conditions. Stable isotope tracing in HPLM revealed TME-dependent and TME-independent features of tumor metabolism. Tissue explants recapitulated tumor cell-intrinsic metabolic activities, such as synthesis of immunomodulatory purines. Unlike GSC monocultures, tissue explants captured tumor cell-extrinsic activities associated with stromal cell metabolism, as exemplified by astrocytic guanosine diphosphate mannose production in heterocellular explants. Finally, glioma explants displayed tumor subtype-specific metabolic reprogramming, including robust pyrimidine degradation in mesenchymal cells. Conclusions: We present a tractable approach to assess glioma metabolism in vitro under physiologic nutrient levels and in the presence of an intact TME. This platform opens new avenues to interrogate glioma metabolism and its interplay with the immune microenvironment.
- 25 October 2025
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (2) , 415-429
Open AccessStable isotope tracing in human plasma-like medium reveals metabolic and immune modulation of the glioblastoma microenvironment
Background: In vivo stable isotope tracing is useful for natively surveying glioma metabolism but can be difficult to implement. Stable isotope tracing is tractable using in vitro glioma models, but most models lack nutrient conditions and cell populations relevant to human gliomas. This limits our ability to study glioma metabolism in the presence of an intact tumor microenvironment (TME) and immune-metabolic crosstalk. Methods: We optimized an in vitro stable isotope tracing approach for human glioma explants and glioma stem-like cell (GSC) lines that integrates human plasma-like medium (HPLM). We performed 15N2-glutamine tracing in GSC monocultures and human IDH-wildtype glioblastoma explants and developed an analytical framework to evaluate microenvironment-dependent metabolic features that distinguish them. We also conducted spatial transcriptomics to assess transcriptional correlates to metabolic activities. Results: Human plasma-like medium culture preserved glioma explant viability and stemness while unmasking metabolic and immune programs suppressed by conventional culture conditions. Stable isotope tracing in HPLM revealed TME-dependent and TME-independent features of tumor metabolism. Tissue explants recapitulated tumor cell-intrinsic metabolic activities, such as synthesis of immunomodulatory purines. Unlike GSC monocultures, tissue explants captured tumor cell-extrinsic activities associated with stromal cell metabolism, as exemplified by astrocytic guanosine diphosphate mannose production in heterocellular explants. Finally, glioma explants displayed tumor subtype-specific metabolic reprogramming, including robust pyrimidine degradation in mesenchymal cells. Conclusions: We present a tractable approach to assess glioma metabolism in vitro under physiologic nutrient levels and in the presence of an intact TME. This platform opens new avenues to interrogate glioma metabolism and its interplay with the immune microenvironment.
- Open Access
- 25 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6845
Neurophysiological evidence of human hippocampal longitudinal differentiation in associative memory
In humans, the hippocampus exhibits evident structural and connectivity differences along the longitudinal axis. Experiments in rodents and more recently in human subjects have stimulated several theories of functional longitudinal specialization. This question pertains directly to the management of neurosurgical patients, as nascent technologies permit more precise treatments that can selectively spare longitudinal regions. With this in mind, we investigated hippocampal longitudinal specialization in 32 human intracranial EEG subjects as they performed an associative recognition episodic memory task. Utilizing the behavioral contrasts available in this task, we characterize the neurophysiological features that distinguish the anterior versus posterior hippocampal activity during recollection and familiarity-based memory retrieval, as well as novelty processing. We use subspace representations to characterize longitudinal differences in the temporal dynamics of key computational processes ascribed to the hippocampus, namely pattern separation and pattern completion. We place our findings in the context of existing models, adding to sparse literature using direct brain recordings to explicate the functional differentiation along the hippocampal longitudinal axis in humans.
- 25 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6845
Open AccessNeurophysiological evidence of human hippocampal longitudinal differentiation in associative memory
In humans, the hippocampus exhibits evident structural and connectivity differences along the longitudinal axis. Experiments in rodents and more recently in human subjects have stimulated several theories of functional longitudinal specialization. This question pertains directly to the management of neurosurgical patients, as nascent technologies permit more precise treatments that can selectively spare longitudinal regions. With this in mind, we investigated hippocampal longitudinal specialization in 32 human intracranial EEG subjects as they performed an associative recognition episodic memory task. Utilizing the behavioral contrasts available in this task, we characterize the neurophysiological features that distinguish the anterior versus posterior hippocampal activity during recollection and familiarity-based memory retrieval, as well as novelty processing. We use subspace representations to characterize longitudinal differences in the temporal dynamics of key computational processes ascribed to the hippocampus, namely pattern separation and pattern completion. We place our findings in the context of existing models, adding to sparse literature using direct brain recordings to explicate the functional differentiation along the hippocampal longitudinal axis in humans.